FDA official logo
GSRS logo
PFDA official logo

RISANKIZUMAB

  • UNII: 90ZX3Q3FR7
  • Preferred Substance Name: RISANKIZUMAB

  • 1612838-76-2
  • 655066-01
  • ABBV-066
  • BI-655066
  • IMMUNOGLOBULIN G1, ANTI-(HUMAN INTERLEUKIN 23 SUBUNIT P19) (HUMAN-MUS MUSCULUS HEAVY CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS .KAPPA.-CHAIN, DIMER
  • IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS IL23A (INTERLEUKIN 23 SUBUNIT ALPHA, IL-23A, IL23 SUBUNIT P19, IL23P19)), HUMANIZED MONOCLONAL ANTIBODY
  • RISANKIZUMAB [INN]
  • RISANKIZUMAB [JAN]
  • RISANKIZUMAB [MI]
  • RISANKIZUMAB [USAN]
  • RISANKIZUMAB [WHO-DD]
  • RISANKIZUMAB RZAA [WHO-DD]
  • RISANKIZUMAB-RZAA
  • SKYRIZI

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.